KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global home infusion therapy market is estimated to be valued at US$ 1,995.3 million in 2020 and is expected to exhibit a CAGR of 6 ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen (AB), a global healthcare company, today announces a program designed to help hospitals and health systems launch or optimize home infusion ...

Option Care Health gives investors exposure to two healthcare megatrends: (i) the shift to healthcare delivery in the home; and (ii) the development of specialty pharmaceuticals. I believe OPCH holds ...

SOMERSET, Wis. (WCCO) — Home infusion is meant to help patients become independent and resume normal activities while recovering from an illness. The COVID-19 pandemic jump-started the growth of the ...

Editor's note: This article was updated to add comments from the National Home Infusion Association. Between 2008 and 2019, the use of home infusion therapy grew by 300%, according to the National ...

Original Medicare provides coverage for IV infusion therapy when a doctor determines it to be medically necessary, both in a clinic setting and at home. Medicare Advantage (Part C) plans need to offer ...

Option Care Health, the largest alternative infusion provider, is poised to benefit from the shift to home-based health and the growing specialty pharmaceuticals market. Despite the 13% drop YTD, OPCH ...

At WHX 2026 Dubai, Alexei Cernenco, OSAA Innovation Board Member and QA/RA Manager, outlines how domiciliary IV therapy is evolving from a niche offering into a strategic component of regional ...